Compare Honeywell International Inc (HON) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Honeywell International Inc trades at $207.87 (market cap $65.48B), while Relay Therapeutics Inc. Common Stock trades at $17.84 (market cap $3.82B). The key difference: Honeywell International Inc is far larger — about 17.1× Relay Therapeutics Inc. Common Stock's market cap, and Honeywell International Inc pays a 1.36% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Honeywell International Inc for 90 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| HON | RLAY | |
|---|---|---|
Market Cap | $65.48B | $3.82B |
Volume | 2,047,782 | 4,332,079 |
Sector | Industrials | Health |
52-Week High | $248.79 | $20.75 |
52-Week Low | $188.14 | $6.03 |
Typical Hold Time | 90 Days | 0 Days |
Enterprise Value | $90.27B | $2.93B |
Dividend Yield | 1.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Honeywell International (HON) trades at $208.11, down 2.24% on the day, with a bearish technical signal from moving averages but strong fundamentals including a low P/E of 7.94 and robust ROE of 47.43%. Recent earnings beats and a $300 million refinery project win highlight operational strength, while the company's post-spin focus on automation drives growth expectations.
The outlook is positive with a consensus price target of $259.25 implying 24.6% upside, supported by analyst bullishness (66.7% buy ratings). Risks include rising debt-to-asset ratios and cyclical exposure, but solid cash flow and dividend payments provide stability amid near-term volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
